leadf
logo-loader
viewMiMedx

MiMedx's Mark Landy Presents at the Biotech Capital Conference

MiMedx's Mark Landy Presents at the Biotech Capital Conference 

Quick facts: MiMedx

Price: 6.68 USD

NASDAQ:MDXG
Market: NASDAQ
Market Cap: $741.78 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Tetra Bio-Pharma completes toxicology studies on coronavirus candidate,...

Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) CEO Guy Chamberland tells Proactive it has completed toxicology studies on its coronavirus drug candidate ARDS-003, clearing the path for human clinical trials. Chamberland says next steps include structuring the applications to begin in-human...

39 minutes ago

2 min read